A comparative study of combination of Myo-inositol and D-chiro-inositol versus Metformin in the management of polycystic ovary syndrome in obese women with infertility
Polycystic ovary syndrome (PCOS) is a symptom complex associated with increased amounts of circulating androgens in females, increased insulin resistance and obesity. The drugs, Myo-inositol, D-chiro-inositol and Metformin, which are insulin sensitizers, are very helpful in taking care of one of the...
Main Author: | Sujana Thalamati |
---|---|
Format: | Article |
Language: | English |
Published: |
Publishing House TRILIST
2020-12-01
|
Series: | Репродуктивная эндокринология |
Subjects: | |
Online Access: | http://reproduct-endo.com/article/view/222111 |
Similar Items
-
Results of treatment with myo-Inositol and D-chiro inositol combination in ratio 5:1 in women with polycystic ovary syndrome
by: Tatiana A. Oboskalova, et al.
Published: (2020-12-01) -
Polycystic Ovary Syndrome: Insights into the Therapeutic Approach with Inositols
by: Maria A. Sortino, et al.
Published: (2017-06-01) -
Myo-inositol effects in women with PCOS: a meta-analysis of randomized controlled trials
by: Vittorio Unfer1,, et al.
Published: (2017-10-01) -
Inositol treatment for PCOS should be science-based and not arbitrary
by: S. Roseff, et al.
Published: (2020-11-01) -
PCOS and Inositols: Controversial Results and Necessary Clarifications. Basic Differences Between D-Chiro and Myo-Inositol
by: Giovanni Monastra, et al.
Published: (2021-04-01)